Page 238 | ASweetLife

Positive Results for DiaPep277 Type 1 Diabetes Treatment in Phase 3 Study

Andromeda Biotech has announced positive initial results from a pivotal phase III clinical study of type 1 diabetes treatment, DiaPep227. The 24-month randomized, placebo-controlled study was designed to assess the safety and efficacy of DiaPep277, a novel immunotherapeutic agent for the treatment of newly diagnosed patients with type 1 diabetes...

Don’t Bolus For Blood: Catherine Price’s Unusual Feast

In Mongolia, blood is considered a valuable food that should not be wasted.

Lose to count

A private thread inturned loose red and not wool a private thread and I run my finger along it not a day not a moment pauses the count one and two…

Little Things We’re Grateful For

It's almost Thanksgiving, the time of year when we, like many others, focus on how grateful we are for the good things in life. Mike and I are incredibly grateful for the life we share and for the family we've created together. Diabetes does take a toll on us, but overall we're doing okay. We're not complaining.

Telling Diabetes Like It Is

I went to the dermatologist on Tuesday with my eight-year-old son. The appointment was for both of us. As I always do at doctors’ appointments,…

Disappointing Results for GSK’s New Type 2 Diabetes Drug Albiglutide (Tanzeum)

Results showed a reduction in HbA1c of 0.78% for patients receiving albiglutide compared to a reduction of 0.99% for liraglutide. While albiglutide did demonstrate a statistically significant reduction in HbA1c from baseline (p<0.001), it did not meet the pre-specified primary endpoint of non-inferiority to liraglutide...